[11C]MCG For Imaging NAALADase/PSMA

Case ID:

C03997

Disclosure Date:

1/4/2002

The present invention relates to compounds particularly asymmetric urea compounds which are labeled with one or more radioisotopes and which are suitable for imaging or therapeutic treatment of tissues, organs, or tumors which express NAALADase and/or PSMA. In another embodiment, the invention relates to methods of imaging tissues, organs, or tumors using radiolabeled compounds of the invention, particularly tissues, organs, or tumors which express NAALADase and/or PSMA to which the compounds of the invention have an affinity.

Patent Information:

Title	App Type	Country	Serial No.	Patent No.	File Date	Issued Date	Expire Date	Patent Status
Imaging Agents and Methods of Imaging NAALADase and PSMA	ORD: Ordinary Utility	United States	10/340,864	7,408,079	1/10/2003	8/5/2008	3/14/2024	Granted

Direct Link:

https://jhu.technologypublisher.com/technology/24623

Inventors:

Category(s):

Clinical and Disease Specializations, Clinical and Disease Specializations > Neurology, Technology Classifications > Medical Devices > Imaging, Technology Classifications > Medical Devices,

Get custom alerts for techs in these categories/from these inventors:

Subscribe for JHTV Updates

For Information, Contact:

Jeanine Pennington

jpennin5@jhmi.edu

410-614-0300

Save This Technology:

Bookmark this page

Download as PDF